Top Markets
#1 Purr Purr +36.78%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +36.52%
#3 OriginTrail OriginTrail +22.13%
#4 Wrapped XPL Wrapped XPL +18.96%
#5 ApeX ApeX +18.89%
#6 UnifAI Network UnifAI Network +17.95%
#7 Plasma Plasma +17.84%
#8 Unit Plasma Unit Plasma +17.84%
#9 Non-Playable Coin Non-Playable Coin +15.81%
#10 Morpho Morpho +15.72%
Coin of the day
Purr Purr
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Rangering i aksjer #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Aksjekurs
$0.84903405
Sist synkronisert: 2026-07-27
Markedsverdi
$106.63M
Endring (1 dag)
0.00%
Endring (1 år)
38.69%
Land
TW
Handel Genovate Biotechnology Co., Ltd. (4130)

Kategori

Healthcare
Inntekter for Genovate Biotechnology Co., Ltd. (4130)
Inntekter i 2026 TTM: 0
Ifølge Genovate Biotechnology Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Genovate Biotechnology Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH